MetaCap

Who Owns Bambusa Therapeutics Stock?

NASDAQ: BBTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

16.00+0.45 (+2.89%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
23.88%
Institutional holders
3
  • Institutions 23.9%
  • Insiders 40.6%
  • Public and other 35.6%

Who owns Bambusa Therapeutics stock?

Institutional investors own about 23.9% of Bambusa Therapeutics's shares, spread across 3 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 40.56% of BBTX.

Summary generated from market data by MetaCap's automated system. Methodology

Frequently asked questions

What percentage of Bambusa Therapeutics is owned by institutions?

Institutions own about 23.9% of BBTX shares and 40.2% of the public float.

How much of Bambusa Therapeutics do insiders own?

Insiders, such as officers and directors, own about 40.56% of BBTX shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related